Remove Compound Screening Remove Screening Hits Remove Trials
article thumbnail

Target-directed cancer: protein-ligand interactions  

Drug Target Review

The mission of the CCDD is to discover novel small-molecule therapeutics for the treatment of cancer and progress them to hypothesis testing phase 1 clinical trials. The team that I lead within the CCDD is called the Hit Discovery and Structural Design Team. We need to build the assays that we need for compound screening.